Literature DB >> 11324688

Genetic basis of autoimmune disease in MRL/lpr mice: dissection of the complex pathological manifestations and their susceptibility loci.

M Nose1, M Nishihara, J Kamogawa, M Terada, S Nakatsuru.   

Abstract

MRL/MpJ-lpr/lpr (MRL/lpr) mice spontaneously develop various forms of autoimmune disease in the same individuals, including glomerulonephritis, polyarteritis, arthritis and sialoadenitis. An MRL recombinant congenic strain of mice bearing the gld gene, MRLiMpTn-gld/gld (MRL/gld), also develops lesions similar to those in MRL/lpr mice. The lpr and gld genes are a Fas deletion mutant and a Fas ligand mutant, respectively. Thus, autoimmune disease in these mice seemed to be a single gene disease involving the complex pathological manifestations as pleiotropy. However, comparative studies with C3H/HeJ and C57BL/6J strains of mice bearing lpr or gld revealed that these lesions developed only in mice with an MRL background. Moreover, these lesions were genetically segregated among MRL/lpr x (MRL/lpr x C3H/lpr)F1 mice. This indicates that an MRL strain has particular gene(s) affecting the development of each lesion. Association studies of each lesion with polymorphic microsatellite markers using backcross mice revealed that gene loci responsible for each lesion exist at different chromosomal positions and have additive and hierarchical properties of polygenic inheritance for some of the lesions. We conclude that the complex pathological manifestations of autoimmune disease are under the control of different combinations of polygenes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11324688

Source DB:  PubMed          Journal:  Rev Immunogenet        ISSN: 1398-1714


  11 in total

1.  IL-3 contributes to development of lupus nephritis in MRL/lpr mice.

Authors:  Kerstin Renner; Fabian Johannes Hermann; Kathrin Schmidbauer; Yvonne Talke; Manuel Rodriguez Gomez; Gabriela Schiechl; Jens Schlossmann; Hilke Brühl; Hans-Joachim Anders; Matthias Mack
Journal:  Kidney Int       Date:  2015-07-01       Impact factor: 10.612

2.  High expression of interleukin-1beta in the corneal epithelium of MRL/lpr mice is under the control of their genetic background.

Authors:  M Okamoto; M Takagi; M Kutsuna; Y Hara; M Nishihara; M C Zhang; T Matsuda; M Sakanaka; S Okamoto; M Nose; Y Ohashi
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

Review 3.  Genetic defects of apoptosis and primary immunodeficiency.

Authors:  Helen C Su; Michael J Lenardo
Journal:  Immunol Allergy Clin North Am       Date:  2008-05       Impact factor: 3.479

4.  Lymphocytes with aberrant expression of Fas or Fas ligand attenuate immune bone marrow failure in a mouse model.

Authors:  Stephanie O Omokaro; Marie J Desierto; Michael A Eckhaus; Felicia M Ellison; Jichun Chen; Neal S Young
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

5.  Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus: relation to the organ damage and lymphocytes apoptosis.

Authors:  Lian-Hong Li; Wen-Xian Li; Ou Wu; Guo-Qing Zhang; Hai-Feng Pan; Xiang-Pei Li; Jian-Hua Xu; Hong Dai; Dong-Qing Ye
Journal:  Mol Biol Rep       Date:  2008-11-20       Impact factor: 2.316

6.  C3a receptor deficiency accelerates the onset of renal injury in the MRL/lpr mouse.

Authors:  Scott E Wenderfer; Hongyu Wang; Baozhen Ke; Rick A Wetsel; Michael C Braun
Journal:  Mol Immunol       Date:  2009-01-23       Impact factor: 4.407

7.  Fas/CD95 prevents autoimmunity independently of lipid raft localization and efficient apoptosis induction.

Authors:  Anthony C Cruz; Madhu Ramaswamy; Claudia Ouyang; Christopher A Klebanoff; Prabuddha Sengupta; Tori N Yamamoto; Françoise Meylan; Stacy K Thomas; Nathan Richoz; Robert Eil; Susan Price; Rafael Casellas; V Koneti Rao; Jennifer Lippincott-Schwartz; Nicholas P Restifo; Richard M Siegel
Journal:  Nat Commun       Date:  2016-12-23       Impact factor: 14.919

8.  The lupus-susceptibility gene kallikrein downmodulates antibody-mediated glomerulonephritis.

Authors:  Q-Z Li; J Zhou; R Yang; M Yan; Q Ye; K Liu; S Liu; X Shao; L Li; X-J Zhou; E K Wakeland; C Mohan
Journal:  Genes Immun       Date:  2009-03-05       Impact factor: 2.676

Review 9.  Current status of lupus genetics.

Authors:  Andrea L Sestak; Swapan K Nath; Amr H Sawalha; John B Harley
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

10.  Analysis of C4 and the C4 binding protein in the MRL/lpr mouse.

Authors:  Scott E Wenderfer; Kipruto Soimo; Rick A Wetsel; Michael C Braun
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.